mRNA vaccine politics: responsible governance coordination for vaccine innovation in times of urgency
COVID-19 crisis reaffirmed the power of a few companies to scale up production for mRNA vaccines, which created injustice as a few nations in the developed world benefited first from available vaccines, while LMICs waited at the back of the queue. Initiatives such as the South Africa mRNA tech trans...
Saved in:
| Main Author: | Katerina Sideri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Responsible Innovation |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/23299460.2024.2425121 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01) -
Research progress of mRNA vaccines for infectious diseases
by: Zhen Zhang, et al.
Published: (2025-08-01) -
Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01) -
Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
by: Ziqi Cheng, et al.
Published: (2024-12-01) -
mRNA vaccine designs for optimal adjuvanticity and delivery
by: Yuki Mochida, et al.
Published: (2024-12-01)